<DOC>
	<DOCNO>NCT00002897</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . It know whether chemotherapy surgery effective surgery alone treat cancer esophagus . PURPOSE : Randomized phase III trial compare effectiveness surgery without chemotherapy treat patient stage II stage III cancer esophagus .</brief_summary>
	<brief_title>Surgery With Without Chemotherapy Treating Patients With Stage II Stage III Cancer Esophagus</brief_title>
	<detailed_description>OBJECTIVES : I . Compare resectability survival patient stage II/III esophageal cancer treat neoadjuvant cisplatin/fluorouracil vs. surgery alone . OUTLINE : This randomize study . Patients randomize one two group . The first group receive cisplatin fluorouracil every 4 week 3 course follow esophagectomy regional lymphadenectomy . The second group undergo esophagectomy regional lymphadenectomy alone . All patient follow survival . PROJECTED ACCRUAL : A total 240 patient enter 4 year .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm esophageal squamous cell cancer stage T23 Nx M0 PATIENT CHARACTERISTICS : Age : 18 75 Performance status : WHO 02 Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No second malignancy within 5 year except : Basal cell skin carcinoma Carcinoma situ cervix PRIOR CONCURRENT THERAPY : No prior chemotherapy radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>stage II esophageal cancer</keyword>
	<keyword>stage III esophageal cancer</keyword>
	<keyword>squamous cell carcinoma esophagus</keyword>
</DOC>